BioPharm America 2014: Interview with Gary Nabel, Sanofi

July 7, 2015
John Carroll, Editor-in-Chief of FierceBiotech, interviews Gary Nabel, CSO of Sanofi, at BioPharm America 2014 in Boston on September 22. Nabel discusses recent licensing collaboration deals and the key attributes in terms of technology or culture that Sanofi looks for when considering a biotech collaboration. Find more videos and articles at http://www.partnering360.com/insight For more information on BioPharm America, visit our webpage: http://www.ebdgroup.com/bpa/index.php
Previous Article
Patient-centric Baxalta capitalizes on Cambridge
Patient-centric Baxalta capitalizes on Cambridge

When Baxalta Incorporated spun out of Baxter on July 1, it already qualified as "big pharma." With USD 6 bi...

Next Video
BIO-Europe Spring 2015: Interview with Angele Maki, Genentech
BIO-Europe Spring 2015: Interview with Angele Maki, Genentech

Genentech is striking bold moves into whole genome sequencing. Angele Maki of Genentech discusses the strat...